Pharmacyte Biotech Stock Climbs 1.49% to $0.35 Amid Market Shift
Pharmacyte Biotech (PMCB) up 1.49% with a $0.35 price, 10.7 m shares, $3.7 m cap—live‑cell encapsulation tech for cancer & diabetes.
- PHARMACYTE BIOTECH INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read